mBio · 2019 · 26 citations · 24 references
Life SciencesInfectious DiseasesMedicinal ChemistryHost-pathogen InteractionsMolecular VirologyVirologyAntiviral AgentsArboviral DiseasesHost-virus InteractionsViral InfectionsViral PathogenesisVirus-host InteractionsAntiviral Drug DesignAntiviral TherapeuticsHost-targeted AntiviralsPathogen-host Interaction TargetingSirtuin PathwaysSirtuin RegulationViral Replication InhibitorsWest Nile Virus Disease
Arthropod-borne viruses are diverse pathogens and are associated with human disease. Through high-throughput drug screening, we found that sirtuin inhibitors are potently antiviral against diverse arboviruses, including flaviviruses such as West Nile virus, bunyaviruses such as Rift Valley fever virus, and alphaviruses such as chikungunya virus. Sirtuin inhibitors block infection of these viruses in multiple human cell types. Moreover, we found that sirtuin inhibitors arrest infection downstream of entry but that they do so at an early step, preventing the accumulation of viral RNA and protein. Since these viruses infect vector insects, we also tested whether sirtuin inhibitors impacted infection of adult flies and found that these inhibitors blocked infection; therefore, they target highly conserved facets of replication. Taken together, these results suggest that sirtuin inhibitors represent a new class of potent host-targeting antivirals.
24
Roy A. Frye · Biochemical and Biophysical Research Communications · 1999 · 805 citations
Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator
Jonathan J. Hollick, Johanna Campbell, Oliver Staples et al. · Cancer Cell · 2008 · 523 citations · Full text
Medicine, Oncology, Pharmacology +13